Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Edaravone

Various toxicities: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yang L, et al. Edaravone administration and its potential association with a new clinical syndrome in cerebral infarction patients: Three case reports. World Journal of Clinical Cases 11: 4648-4654, No. 19, 06 Jul 2023. Available from: URL: https://www.wjgnet.com/2307-8960/about.htm Yang L, et al. Edaravone administration and its potential association with a new clinical syndrome in cerebral infarction patients: Three case reports. World Journal of Clinical Cases 11: 4648-4654, No. 19, 06 Jul 2023. Available from: URL: https://​www.​wjgnet.​com/​2307-8960/​about.​htm
Metadaten
Titel
Edaravone
Various toxicities: 3 case reports
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-44967-z

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drug

Case report

Pembrolizumab

Case report

AZD 1222

Case report

Retinol